NCT06184100 Virtual Self-Management Program for JIA
| NCT ID | NCT06184100 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Juvenile Idiopathic Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-13 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-12-13 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.
Eligibility Criteria
Inclusion Criteria: 1. Adolescents between the ages of 12 and 17 2. Confirmed diagnosis within 2 years according to the International League of Associations for Rheumatology JIA classification criteria (2) 3. Followed in one of the pediatric rheumatology clinics participating in the RCT 4. Able to access the Internet on a computer 5. Willing and able to complete online measures Exclusion Criteria: 1. Insufficient English reading and speaking skills 2. Untreated psychiatric or comorbid disorders or major cognitive impairments leading to inability to understand materials and participate in the SMP group activities. 3. Other chronic conditions such as other autoimmune disease, neurologic, orthopedics or other systems disorder (e.g. heart, kidney) that might influence outcome assessments 4. Past participation in the last year or participating in another peer-support or self-management program
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06184100 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Juvenile Idiopathic Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06184100 currently recruiting?
Yes, NCT06184100 is actively recruiting participants. Contact the research team at SchmelingResearch@albertahealthservices.ca for enrollment information.
Where is the NCT06184100 trial being conducted?
This trial is being conducted at Calgary, Canada.
Who is sponsoring the NCT06184100 clinical trial?
NCT06184100 is sponsored by University of Calgary. The trial plans to enroll 100 participants.